PAPILLARY THYROID CANCER
Clinical trials for PAPILLARY THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY THYROID CANCER trials appear
Sign up with your email to follow new studies for PAPILLARY THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare gene fusions in multiple cancers
Disease control OngoingThis phase 2 study tests the drug entrectinib in over 500 people with advanced solid tumors that have specific gene changes (NTRK, ROS1, or ALK fusions). The goal is to see if the drug can shrink tumors and control the disease. Participants have various cancer types, including lu…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Radioactive iodine: unnecessary for some thyroid cancer patients?
Disease control OngoingThis study looks at whether low-risk thyroid cancer patients need radioactive iodine treatment after having their thyroid removed. About 504 participants are randomly assigned to receive either a standard dose of radio-iodine or no radio-iodine at all. The goal is to see if skipp…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2, PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Targeted drug may shrink thyroid tumors before surgery
Disease control OngoingThis study tests the drug vemurafenib in 24 people with advanced papillary thyroid cancer that has a BRAF gene mutation. The drug aims to block this mutation to shrink tumors before surgery. Researchers will measure changes in tumor size and biomarkers in blood and tissue over 56…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New oral drug shows promise for kids with rare RET-Driven cancers
Disease control OngoingThis study tests an oral drug called selpercatinib (LOXO-292) in children with advanced solid or brain tumors that have a specific RET gene change. The trial has two parts: first finding a safe dose, then measuring how many children's tumors shrink. About 36 children whose cancer…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Watchful waiting vs surgery: new study on tiny thyroid tumors
Disease control OngoingThis study looks at two ways to manage very small, low-risk papillary thyroid cancers: active surveillance (regular check-ups to monitor the cancer) or immediate surgery. Researchers are tracking 450 adults over time to see how often each approach meets long-term goals, such as a…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy shows promise for Radioiodine-Resistant thyroid cancer
Disease control OngoingThis phase 2 trial tests a combination of the immunotherapy drug PDR001 with either trametinib or dabrafenib in 19 patients with thyroid cancer that no longer responds to radioiodine treatment. The goal is to see if the combination can shrink tumors. The study is active but no lo…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Urine test may spot hidden thyroid cancer, avoid unnecessary surgery
Diagnosis OngoingThis study looks at whether proteins found in urine can help doctors diagnose follicular thyroid cancer before surgery. Currently, this type of thyroid cancer can only be confirmed after removing the thyroid. Researchers will collect urine samples from 50 patients with thyroid no…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Pee power: urine test could replace blood draws for thyroid cancer Follow-Up
Knowledge-focused OngoingThis study is testing whether substances found in urine can help doctors monitor thyroid cancer after treatment. Researchers are collecting urine samples from 103 people who had their thyroid removed and/or radioactive iodine therapy. They are looking for specific proteins in the…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC